Hodgkin Lymphoma Research Updates From Dr. Joshua Brody

Published on

Topics include: Treatment

What’s new for those living with Hodgkin lymphoma? Although today’s standard of care cures some, the ever-evolving field of cancer research is finding innovative approaches to benefit a greater number of patients. Noted expert Dr. Joshua Brody, from Mount Sinai School of Medicine, discusses recent advances in immunotherapy, anti-body drug conjugates, targeted and combination therapies for Hodgkin lymphoma patients. Dr. Brody also shares results from the ECHELON-1 trial, the rate of progression-free survival, and how the side effect profile compares to standard therapies. Were U.S. patients more or less responsive? Which patients are these novel agents suitable for? Watch now to stay up-to-date with the latest research and treatment developments.

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

View more programs featuring and

Related Programs

Dan's Story: My Experience With CAR T-Cell Therapy

Following several unsuccessful rounds of treatment for B-cell non-Hodgkin lymphoma, Dan was told that he only had a few months to live. Hear his experience on a CAR T-cell therapy clinical trial.


Lymphoma Research and Treatment Update From ASH 2017

Dr. Andrew Evens gives us an update from ASH 2017 about new treatments for both Hodgkin and non-Hodgkin lymphoma. Watch to learn the latest from ASH 2017.


Treating Hodgkin Lymphoma: New Treatments on the Horizon

Host Andrew Schorr catches up with expert Dr. Stephen Ansell, leader of the Lymphoma Group at Mayo Clinic in Rochester, Minnesota, at the 2017 ASCO meeting in Chicago to discuss updates on Hodgkin lymphoma.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on July 11, 2018